Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
Modified High-Dose versus High-Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis - Transplantation and Cellular Therapy, Official Publication of the American Society ...
Gastrointestinal Toxicity of High-Dose Melphalan in Autologous Stem-Cell Transplantation: Identification of Risk Factors and a Benchmark for Experimental Therapies - Biology of Blood and Marrow Transplantation
The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy. | Semantic Scholar
Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma | Haematologica
Algorithm for patient selection and treatment with high-dose melphalan... | Download Scientific Diagram
High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review | Bone Marrow Transplantation
Hematopoietic recovery after high-dose melphalan and PBPC rescue | Download Table
Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study - ScienceDirect
A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001) | PLOS ONE
Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis | Bone Marrow Transplantation
Complications of high-dose Melphalan. | Download Table
High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan - The Lancet Haematology
813-Autologous conditioning high dose melphalan 140 mg/m<sup>2</sup> | eviQ
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis | NEJM
High-Dose Melphalan and the Development of Hematopoietic Stem-Cell Transplantation: 25 Years Later | Journal of Clinical Oncology
Role of high-dose Melphalan & ASCT | Int'l Myeloma Fn
Frontiers | Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy
Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma | Bone Marrow Transplantation
BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma. | Semantic Scholar
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma | NEJM
